You are visiting us from Virginia. You are located in HHS Region 3. Your Center is Central East ATTC.
What is the Addiction Technology Center Network (ATTC)?
Learn More
Online Learning Opportunities on HealtheKnowledge
Free and Low Cost Continuing Education for Healthcare Providers
Learn More
Fentanyl and Overdose Products and Events
Browse our list of new products and upcoming events
View Resources
What is the Addiction Technology Center Network (ATTC)?
Learn More
Online Learning Opportunities on HealtheKnowledge
Free and Low Cost Continuing Education for Healthcare Providers
Learn More
Fentanyl and Overdose Products and Events
Browse our list of new products and upcoming events
View Resources

The Addiction Technology Transfer Centers (ATTCs) play a critical role in advancing our nation's health by equipping healthcare professionals and community organizations with effective tools to address individuals, children, and families impacted by alcohol and drug use. We build local capacity of the behavioral health workforce resulting in treatment that leads to long-term recovery. ATTCs' no-cost services are aligned with national goals to reduce overdose fatalities and combat the opioid crisis while decreasing the burden on criminal justice and social service systems. Training treatment and recovery providers nationwide saves billions in taxpayer dollars, while also fostering safer and healthier communities.

ME NY PA VA WV AL GA FL KY TN MS SC NC MN WI MI IL IN OH TX NM OK AR LA NE IA KS MO ND SD MT WY UT CO CA NV AZ AK ID OR WA
Hover over your state or region to find your ATTC Center, and click to go to that center's homepage.
Get Connected!
The ATTC Messenger is a monthly e-pub with information and news relevant to the field.
Subscribe Now
Get Informed!
Search our Products & Resources Catalog to find tools you can use to improve services!
Search Products
Get Trained!
Search our calendar of upcoming trainings and events to find a training to fit your needs!
Search Events

Upcoming Events

Webinar/Virtual Training
Description: The Diagnostic Statistical Manual for Mental Disorders (DSM-5-TR) includes substance use disorders along with a myriad of other psychiatric conditions that have similar symptomology. Screening for substance use can help to discern between symptoms that may seem to result from a mental health condition but may actually be substance use related. By incorporating screening, brief interventions and referral to treatment (SBIRT) in practice, clinicians can identify and intervene with individuals who are experiencing psychosocial or health conditions related to their substance use. This interactive learning event will review intersections of psychoactive substances and mental illness, impact on mental illness diagnosis and treatment, and benefits of how SBIRT can augment successful outcomes for individuals with co-occurring disorders. *Please note* Tickets are not needed for this event. The Zoom link will be included in the confirmation and reminder emails. Trainer: Diana Padilla, MCPC, CTSS, CARC Credits: This training has been approved for three renewal hours (CASAC, CPP, CPS) and three initial hours (CPP, CPS) through New York State’s Office of Addiction Services and Supports (NYS OASAS). As an IC & RC member board, OASAS accredited courses are granted reciprocal approval by the New Jersey Division of Consumer Affairs, Alcohol and Drug Counselor Committee. Many other states offer reciprocity - please check with your accrediting agency. Additionally, Research Foundation for Mental Hygiene, Inc., Training Institute is recognized by the New York State Education Department's State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0694. Participants are required to attend the ENTIRE training, turn on their video cameras and actively participate in order to receive a certificate of completion.
Face-to-Face Training
Description: Understand what the SBIRT Model is. Define what are narcotic, depressant, stimulant and hallucinogenic substances and differentiate the effects on the Central Nervous System. Understand the procedures of the SBIRT Model. Encourage group level case discussions. Apply the SBIRT Model.
Face-to-Face Training
Closed event for staff at Empower Somerset Description: SBIRT is a practice that uses a preventive public health approach to identify and intervene with persons whose pattern of substance use puts them at risk for or are experiencing substance-related health problems. SBIRT also identifies essential elements of effective referrals to specialty care for persons with a high potential for substance use disorders. Because many people do not meet the criteria of alcohol or substance use disorder and are potentially impacting their health and wellness, SBIRT uses a culturally appropriate and recovery-oriented framework to address a person’s risky behavior and as a model, can be integrated into health care and behavioral health settings. This course will review validated instruments to screen for substance use, how to provide a brief intervention, and essential components of successful facilitation of referrals to specialized care.
Browse More Events

New Products & Resources

Multimedia
Women who use drugs are at disproportionate risk of exposure to HIV and HCV, inadequate healthcare access, and interpersonal violence. While harm reduction practices are shown to improve outcomes associated with substance use, women experience unique barriers to accessing these services, including overlapping forms of stigma, fears of criminal-legal involvement, gender-based violence, and limited gender-responsive programming. Providers and organizations who work with women who use drugs should develop methods for bridging gaps in care based on the latest evidence. This talk from Alex Rains, MD, of Brigham and Women's Hospital in Boston, MA, explored the current landscape of care for women who use drugs and equip providers with strategies to combat stigma and meet the healthcare needs of this community.
Toolkit
DESCRIPTION Challenges in processing information is a critical consideration for providers engaging in prevention and outreach to people living with substance use disorder. To empower assessment and intervention, providers need to increase their skills in information gathering and sharing with people whose diagnoses contain a cognitive processing barrier. This toolkit will define and exemplify what cognitive processing disorder is, how it presents, and some basic considerations for navigating it. To download the toolkit, please use the CPD Toolkit button on the right side of this page.   This toolkit was developed in collaboration with Laura Hinds of Hindsight Consulting Group, LLC. Laura Hinds MSW, LCSW is a clinical social worker with experience in medical, behavioral and mental health settings. Laura has had the pleasure of working with high acuity special needs populations and their providers for over 22 years. An alumna and instructor at Penn’s School of Social Policy and Practice for 13 years, and Bryn Mawr’s School of Social Work and Social Research for the past 4 years, Laura has supported the learning and education of new social workers, veterans in the field, and their interdisciplinary partners.
Multimedia
This is a recording of the webinar presented on March 19, 2025 with Kate Speck, PhD, MAC, LADC. The 90-minute ethics webinar will equip behavioral health professionals with an understanding of ethical principles for application in their professional roles. Emphasizing the significance of ethical values in human service practice, this presentation will explore topics relevant to professionals in addiction, gambling, mental health, case management, social work, vocational rehabilitation, and justice fields, particularly serving in rural areas. Discussion of ethical responsibility, recognizing personal core values underpinning ethical practice, examining an ethical decision-making model, and understanding the context of therapy will be addressed.
Browse More Products and Resources
Exciting news! The University of Wisconsin–Madison recently received grant funding from the Substance Abuse and Mental Health Services Administration (SAMHSA) to establish the Center for Mental Health Implementation Support (CMHIS). Adopting an effective mental health program or service is not just about the “what” of the program, but also the “how” of practice change. CMHIS focuses on […]
Read More
The NIATx model is widely recognized for driving rapid-cycle improvements using the essential NIATx tools and steps for change. However, staff turnover, shifting priorities, and limited resources can all contribute to backsliding into old habits. How can organizations make sure that improvements become standard operating procedure? In this post, we’ll explore how embedding the NIATx […]
Read More
This flipbook features a compilation of published blog posts from the ATTC/NIATx Service Improvement Blog that highlights content focused on the use of NIATx principles, tools, and processes to create impactful and lasting organizational change. It also includes information on implementing the NIATx change model in new and diverse settings. By compiling the content according to these […]
Read More
Prevention coalitions often face challenges engaging parents in prevention initiatives, even when those efforts address critical issues like youth substance use or mental health. Here's an example of how a fictional coalition decided to take on this challenge by using the NIATx Plan-Do-Study-Act (PDSA) tool. The small, incremental changes they made helped to increase attendance […]
Read More
The flowchart is one of the essential tools in the NIATx model. A flowchart provides visual map of your process—it shows how things get done, step by step. You might be thinking, “Why do we need a flowchart if we already did a walk-through of the process?" If the process seems straightforward, your team might […]
Read More
Xylazine, medetomidine and nitazines are substances that are emerging as key contributors in the latest wave of the Opioid Overdose Epidemic. Xylazine is an adulterant that increases the duration of a user’s fentanyl high and delays withdrawal to some extent. Medetomidine is another adulterant that belongs to the same family of drugs as xylazine, but […]
Read More
1 2 3 22
map-markermagnifiercrossmenuchevron-down